- Research article
- Open Access
- Open Peer Review
Prevalence of arthritis according to age, sex and socioeconomic status in six low and middle income countries: analysis of data from the World Health Organization study on global AGEing and adult health (SAGE) Wave 1
BMC Musculoskeletal Disorders volume 18, Article number: 271 (2017)
In higher income countries, social disadvantage is associated with higher arthritis prevalence; however, less is known about arthritis prevalence or determinants in low to middle income countries (LMICs). We assessed arthritis prevalence by age and sex, and marital status and occupation, as two key parameters of socioeconomic position (SEP), using data from the World Health Organization Study on global AGEing and adult health (SAGE).
SAGE Wave 1 (2007–10) includes nationally-representative samples of older adults (≥50 yrs), plus smaller samples of adults aged 18-49 yrs., from China, Ghana, India, Mexico, Russia and South Africa (n = 44,747). Arthritis was defined by self-reported healthcare professional diagnosis, and a symptom-based algorithm. Marital status and education were self-reported. Arthritis prevalence data were extracted for each country by 10-year age strata, sex and SEP. Country-specific survey weightings were applied and weighted prevalences calculated.
Self-reported (lifetime) diagnosed arthritis was reported by 5003 women and 2664 men (19.9% and 14.1%, respectively), whilst 1220 women and 594 men had current symptom-based arthritis (4.8% and 3.1%, respectively). For men, standardised arthritis rates were approximately two- to three-fold greater than for women. The highest rates were observed in Russia: 38% (95% CI 36%–39%) for men, and 17% (95% CI 14%–20%) for women. For both sexes and in all LMICs, arthritis was more prevalent among those with least education, and in separated/divorced/widowed women.
High arthritis prevalence in LMICs is concerning and may worsen poverty by impacting the ability to work and fulfil community roles. These findings have implications for national efforts to prioritise arthritis prevention and management, and improve healthcare access in LMICs.
Worldwide, musculoskeletal disorders represent a global threat to healthy ageing , and are ranked as the second most common cause of disability, measured by years lived with disability (YLDs) . Lower and middle income countries (LMICs) are not immune to the burden of musculoskeletal diseases, indeed the prevalence of this non-communicable disease (NCD) group is dramatically increasing in LMICs . The 2010 Global Burden of Disease (GBD) study reported that musculoskeletal diseases accounted for 19.2% of all YLDs in LMICs . Despite this, the majority of the global NCD initiatives do not include musculoskeletal diseases . Significantly contributing to the global disability burden associated with the musculoskeletal system are arthritis diseases. Arthritis is an umbrella term that encompasses in excess of 100 different arthritic conditions which are a chronic, painful, and debilitating group of diseases. Arthritis, specifically osteoarthritis, is a significant contributor to global disability burden, and the YLDs attributable to osteoarthritis have increased by 75% from 1990 to 2013 , indicating this disease as a growing problem internationally. In combination with an increasing trajectory of arthritis prevalence [2, 4], growth in YLDs attributable to arthritis is due primarily to increased life expectancy worldwide, and prolonged exposure to arthritis risk factors .
Compared to higher income countries, many LMICs , where two-thirds of the world’s population resides, have a much lower capacity to pay for adequate healthcare. Indeed, LMICs have 90% of the global burden of disease but only 12% of global health spending . In higher income countries, arthritis is associated with reduced workplace productivity [8, 9]; however, for residents of LMICs, arthritis imposes a potential additional burden by creating a vicious cycle that subsequently worsens poverty . For example, compared to higher income countries, and in context of scarce medical and social support systems, residents of LMICs with arthritis also experience reduced ability to access, afford or utilize treatments including analgesic and anti-inflammatory pharmacotherapies [11, 12], or arthroplasty for advanced disease [13, 14]. They also have, in context of workforce capacity limitations, less flexibility regarding working conditions or hours , and few if any options for early retirement, or social security ‘safety nets’ pertaining to minimum income, including financial and/or material goods.
Whilst the majority of research regarding arthritis prevalence has been undertaken in higher income countries, recent data from the 2010 GBD Study provides some evidence that LMICs may have greater arthritis prevalence than higher income countries . Yet, while valuable population level estimates, extrapolation from these GBD estimates is difficult given that they are based on published prevalence and incidence data from a small number of heterogeneous studies spanning different time periods in a limited number of LMIC . Furthermore, data from multi-country studies of LMICs that have examined prevalence of arthritis across sociodemographic factors are typically not readily available [18, 19], with the exception of a recent publication, which showed that more years of schooling and greater levels of wealth decreased the odds of having an undiagnosed NCD, including arthritis . Understanding the prevalence of arthritis across different parameters of socioeconomic position (SEP) data would augment our global understanding of global arthritis prevalence, social determinants and burden.
To date, country-specific arthritis prevalence across parameters of SEP has not been systematically evaluated in large, nationally representative samples of populations from LMICs. This information is crucial for planning future healthcare delivery for high burden chronic conditions and to ensure sufficient health workforce capacity – both significant concerns in an ageing world . Comprehensive data have been collected in the World Health Organization (WHO) Study on global AGEing and adult health (SAGE) [20, 22, 23], thus providing an important resource to investigate disease prevalence in large population samples from six LMICs. Using SAGE Wave 1, these analyses were undertaken to determine the prevalence of arthritis in LMICs according to age, sex, and socioeconomic position (SEP).
Study population and design
SAGE Wave 1 (2007–10) is a longitudinal study with nationally representative samples of persons aged 50+ years and a smaller sample of adults aged 18–49 years that includes 44,747 adults aged ≥18 years from China, Ghana, India, Mexico, Russian Federation and South Africa . Multistage cluster sampling strategies were used with households as sampling units. Households were classified into one of two mutually exclusive categories: i) all persons aged 50 years and older were selected from “older” households, and ii) one person aged 18–49 years was selected from each “younger” household. An older or younger household was defined by the age of the respondent targeted for individual interview. Household-level and person-level analysis weights were calculated for each country. This research was performed in accordance with the Declaration of Helsinki. The WHO and the respective implementing agency in each country provided ethics approvals. Written, informed consent was obtained from all participants.
Data collection in WHO SAGE
Using a standardized survey instrument to ensure consistency, and based on standardized methods, interviewer training and translation protocols, face-to-face interviews were conducted in China (2008–10; response 93%), Ghana (2008–09; response 81%), India (2007–08; response 68%), Mexico (2009–10; response rate 53%), the Russian Federation (2007–10; response 83%) and South Africa (2007–08; response 75%), as previously published . Full details regarding the probability sampling design, cluster sampling strategies and country-specific areas included in SAGE have been published elsewhere . Briefly, the SAGE questionnaire consisted of household, individual and proxy questionnaires, a verbal autopsy, and appendices: the domains of which are summarised in Table 1 .
Arthritis status: self-reported and symptom-based
For the current analyses, self-reported diagnosis of arthritis (lifetime) was based on participant responses to the question; “Have you ever been diagnosed with/told by a health care professional you have arthritis (a disease of the joints; or by other names rheumatism or osteoarthritis)?” As a secondary endpoint, a symptom-based determination of arthritis (yes/no for current within the previous 12 months) was also employed, by applying an algorithm developed by the WHO SAGE study team ; questions and the algorithm are presented in Table 2.
SEP was measured using two key parameters of marital status and educational attainment: the latter used due to the inextricable link between education and skilled vs. unskilled labour, and thus financial remuneration for work. Self-reported marital status was categorised for analyses into three groups of: (i) never married, (ii) currently married or cohabitating, and (iii) separated/divorced or widowed. Participants were asked if they had ever been to school; for those that indicated ‘yes’, they were also asked to identify the highest level of education completed. Education was categorised as (i) ‘no formal schooling’, (ii) less than primary school, or primary school completed, (iii) secondary school completed, or high school (or equivalent) completed, or (iv) college, pre-university or university completed, or post-graduate degree completed. Education levels were mapped to an international standard .
Arthritis (self-reported and symptom-based) prevalence and 95% confidence intervals (95%CI) were calculated by implementing household level analysis weights separately for each of the six countries across 10-year age strata (the 20–29 year age group was expanded to also include those aged 18–19 years), sex, marital status and education. Country-specific survey weightings were applied, and weighted prevalence calculated for each country. Adjustment of prevalence estimates for differences in the age structure across countries was accomplished by age-standardisation, using the direct method of standardisation  and the WHO World Standard Population distribution (%) as standard population . Ten-year intervals were used for age categorisation.
Country-specific numbers and proportions of the total 44,747 participants (total 57.1% women), were; China n = 15,050 (33.6%), Ghana n = 5573 (12.5%), India n = 12,198 (27.3%), Mexico n = 2752 (6.1%), the Russian Federation n = 4947 (11.1%), and South Africa n = 4227 (9.5%). Across the entire study population, 5003 women and 2664 men had (lifetime) self-reported arthritis (19.9% and 14.1%, respectively), whilst 1220 women and 594 men were identified as having (within previous 12 months) symptom-based arthritis (4.8% and 3.1%, respectively).
Table 3 presents the country-specific proportional responses (non-weighted) to the four symptom-based questions (see Table 2), that were included in the algorithm to determine symptom-based arthritis. For women, proportions that reported ‘any pain during the last 12 months’ or ‘any stiffness during the last 12 months’ were lowest for Mexico (28.4% [95% CI 26.3%–30.9%] and 23.3% [95% CI 20.9%–26.0%], respectively) and highest for the Russian Federation (48.4% [95% CI 46.4%–50.4%] and 50.5% [95% CI 48.8%–52.1%], respectively). For men, the proportions that reported ‘any pain during the last 12 months’ or ‘any stiffness during the last 12 months’ were lowest for Mexico (20.1% [95% CI 17.5%–23.0%] and 16.1% [95% CI%CI 14.1%–18.3%], respectively) and highest for the Russian Federation (32.9% [95% CI 30.5%–35.5%] and 34.6% [95% CI 32.4%–36.9%], respectively).
Table 4 presents the country-specific and sex-stratified prevalence of self-reported arthritis (weighted), across age strata, educational attainment and marital status. For both sexes in each country, arthritis prevalence increased proportionally with advancing age; with the exception of women from China and men and women from South Africa who had the greatest prevalence in the age group of 60–69 years, all other groups showed a peak in arthritis prevalence in the oldest age group ≥70 years. For women, the prevalence by country ranged from 22.9% (95% CI 11.2%–41.1%) in Mexico to 45.7% (95% CI 39.1%–52.3%) in the Russian Federation. For men, prevalence ranged from 9.7% (95% CI 6.3%–14.5%) in Mexico to 37.8% (95% CI 30.3%–46.0%) in the Russian Federation. In each country, women who had never been formally schooled or had completed less than primary school had the highest prevalence of arthritis compared to those with a greater level of educational attainment. Higher arthritis prevalence was consistently observed for women that were separated, divorced or widowed (range: Russian Federation 36.4% [95% CI 29.1%–44.4%] to Ghana 11.7% [95% CI 8.9%–15.1%]) compared to those that were never married or currently married (range: China 0.9% [95% CI 0.3%–3.0%] to South Africa 12.1% [95% CI 5.5%–24.7%]). Similar to women, men that had never been formally schooled had the highest arthritis prevalence, with the exception of men from the Russian Federation, for whom the greatest prevalence was observed in those that had completed all or some primary school level education (39.6% [95% CI 21.3%–61.4%]), however these numbers were small. Compared to other categories, men that were never married had the lowest arthritis prevalence (range: Mexico 0.1% [95% CI 0.0%–0.5%] to India 3.9% [95% CI 1.5%–9.5%]). In China and India, men that were currently married had the highest prevalence (11.9% [95% CI 9.4%–14.8%], and 8.8% [95% CI 7.2%–10.7%], respectively), whilst for all other countries, men that were separated, divorced or widowed were observed to have the highest arthritis prevalence (highest: Russian Federation 33.5% [95% CI 13.3%–62.3%]).
Table 5 presents the country-specific and sex-stratified prevalence of symptom-based arthritis prevalence (weighted), across age strata, educational attainment and marital status, for each LMIC. Patterns of symptom-based arthritis prevalence were similar to self-reported arthritis for both sexes; however, prevalence was lower than observed for self-reported arthritis.
Figure 1 presents a box plot of the age-standardised rates of self-reported arthritis, stratified by sex, across each country (crude and age-standardised rates are presented in Additional file 1: Online Table S1). For five of the six LMICs, the standardised rates of arthritis for men were approximately twice that observed for women; the exception was Ghana, where men had rates three times greater than those observed for women (12% [95% CI 11%–13%] vs. 4% [95% CI 3%–5%]). The highest rates of arthritis were observed in the Russian Federation: for men the rate was 38% (95% CI 36%–39%) and for women it was 17% (95% CI 14%–20%).
We present the prevalence of arthritis across age, sex and different parameters of SEP in a large population-based study spanning six LMICs. Across the countries and for both sexes, higher arthritis prevalence was consistently associated with older age and lower educational attainment, whilst higher prevalence was also observed in women, but not men, that were separated, divorced, or widowed.
The pattern between advancing age and increasing arthritis prevalence in LMICs appears similar to the pattern observed in higher income countries . However, after age-standardisation, we observed in our current study that the rates of arthritis in LMICs were greater than those reported in higher income countries, specifically for men from China, India, the Russian Federation and South Africa. Compared to higher income countries, higher age-standardised rates of arthritis were also observed for women from the Russian Federation; however, for the remaining five LMICs, rates appeared to be similar to those observed from higher income countries. Our results indicate the importance of age-standardisation when reporting prevalence data, in order that fair comparisons can be applied when discussing whether any disparities in diseases exist between countries. In addition to the peak of arthritis prevalence observed in older age groups, we observed a sizeable proportion of arthritis in younger age groups; prevalence that would have significant impacts on work capacity and social roles. Indeed, whilst contextually different and focused upon osteoarthritis, similar findings have been reported in higher income countries [28, 29].
Ours are the first prevalence figures of arthritis to be presented across different socioeconomic parameters for residents of LMICs. Whilst the overall arthritis prevalence has been reported for some countries included the SAGE, specifically India  and China , we now present age-standardised prevalence across all six countries (Additional file 1: Table S1). Higher prevalence of arthritis among individuals with lower educational attainment in LMICs, may be indicative of the inextricable link between lower education and lower-skilled, highly manual labour. Furthermore, these findings also replicate the association observed in higher income countries. For instance, lower educational attainment has been associated with the prevalence of many chronic diseases, including self-reported arthritis (non-specific) , osteoarthritis  and rheumatoid arthritis . Our observation of higher prevalence of arthritis in individuals that were divorced, widowed or separated, may be related to those persons also more likely to be older. However, and whilst speculative, it may plausibly be due to having a greater workload that cannot shared with a partner. Should these individuals also have lower educational attainment, any job-related exposures will likely be manual and thus with greater biomechanical stress on the joints due to increased exposure to heavy lifting, repetitive movements and/or squatting [35, 36].
The prevalence of musculoskeletal diseases per se in LMICs  will potentially have a greater impact than in high income countries due to the reduced capacity of LMICs to avoid and/or alleviate the impact at individual and national levels. This is especially pertinent given that global NCD initiatives do not list musculoskeletal diseases within the ‘top four’ . In LMICs where pain management is less than optimal , the burden of chronic, and possibly untreated, pain will be compounded by social and environmental stressors that require individuals work and fulfil community roles regardless of pain. Indeed, data from a WHO collaboration reported that between 5 and 33% of individuals in LMICs experience chronic pain on a daily basis . Similarly, we observed a sizeable proportion of respondents to have stiffness lasting longer than 30 min and which did not alleviate with movement; these characteristics are indicative of chronic pain, and potentially suggest inflammatory arthropathy. In addition, diseases such as fibromyalgia are likely to cause joint pain, however, we are unable to determine if this, and similar issues, may have biased responses to symptomatology-related questions. Any ‘treatment gap’ is at odds with the WHO Constitution, which recognises “…the highest attainable standard of health as a fundamental right of every human being” , however, LMICs experience a disproportionately lower likelihood of achieving that standard. We speculate that resource-poor populations, where ‘informal workers’ are central to community structure, are most at risk of worsening poverty levels due to increased YLD attributable to highly prevalent, and potentially undertreated, arthritis. It is important to note that whilst the burden of non-communicable diseases is increasing, there is a concurrent decline in the burden of infectious diseases . Given this, more attention must be given to the management of diseases such as arthritis in LMICs: action on musculoskeletal diseases per se in LMICs present opportunities for such action . Models of care (MoC) for musculoskeletal diseases have been developed and implemented in the LMICs of The Philippines, Malaysia, Bangladesh and Myanmar . Despite mixed results, a four-step process was designed to inform future development of musculoskeletal-related MoC for implementation in LMICs; (i) identify the scale of the problem, (ii) identify the need, (iii) develop the action plan (including community engagement and addressing workforce capacity), and (iv) employ a coordinated approach to implementing the intervention program/MoC .
Despite advances in diagnosis and treatment of arthritis during the last few decades in higher income countries , these advances have not impacted on LMICs, which are primarily resource-poor. Gross domestic product and health care expenditures per capita are strongly correlated [14, 41]. Governments in LMICs are constrained by competitive social, economic, health- and poverty-related issues ; this frequently results in chronic diseases such as arthritis achieving lower priority when urgent health needs are considered in an environment with poor education, scarce resources, and rapid population growth [7, 42]. Not only is suboptimal access to healthcare a concern, but the cost of healthcare may be many-fold the gross domestic product, and thus unattainable for the majority of the population of LMICs . For many individuals and households in LMIC, there are inadequate financial resources to manage the cost of chronic disease, with an impoverishing effect of paying for healthcare services out-of-pocket . In order to address the problem of out-of-pocket healthcare expenses, the WHO is encouraging countries to provide universal health coverage . For LMICs the provision of universal health coverage may be in the form of community-based health insurance schemes, whereby the community voluntarily raises, pools, allocates, purchases and supervises the health financing arrangement [7, 44]. Whilst there are some national efforts to prioritise healthcare resources and achieve universal health coverage, these schemes are likely to focus on supporting healthcare for diseases that cause early mortality rather than those that result in disability.
Our study has a number of strengths. The SAGE study consists of a large multi-national cohort, and our population for this analysis encompassed almost 45,000 participants. The integrity and coordination of these data is overseen by WHO, in close collaboration with leading research institutions in each of the countries, and with a level of involvement from national health authorities . The use of a standardized survey instrument and methods for SAGE Wave 1, the recruitment of representative samples, and the application of country-specific weightings to calculate our prevalence estimates have enabled comparison with similar surveys conducted in higher income countries. In addition, the use of standardized tools to measure SEP in each of the countries in SAGE enables us to undertake between-country comparisons. Our findings build on the prevalence data reported by the GBD Study, whereby estimates were based on systematic reviews of published data on incidence, prevalence, and severity; however, for some LMICs only limited data were available . Our study also builds on previous analyses using the SAGE dataset, as no study to date has presented arthritis prevalence figures across parameters of SEP.
This study also has some limitations. We acknowledge that SAGE chronic disease data are self-reported, and thus may be subject to recall bias and potential inaccuracy with a subsequent uncertainty of estimates. However, the self-reported arthritis question is similar to that used for other large population level studies, including those reported by the Centers for Disease Control Arthritis Program in the United States , and self-reported arthritis has also been reported as a sensitive measure for public health surveillance . It is possible that limited access to healthcare professionals in LMICs may lead to an underestimation of arthritis prevalence, and those who have arthritis but have not yet sought care may have been missed. In addition, it may be possible that in many countries diagnoses of arthritis may be made by a non-medical healthcare provider, thus introducing some ambiguity in responses to the diagnosis question. Yet here, the symptom-reported prevalence, where access to healthcare professionals would be removed from the equation, indicated an even lower burden of arthritis than by self-reported diagnosis; an issue that may also be related to diagnosed arthritis being across the lifetime, whilst symptom-based arthritis was within the previous 12 months. Our study does not link prevalence data with disability; however it should be noted that arthritis has highly variable impacts on the person. A high proportion of SAGE Wave 1 participants indicated that they had no formal education (~50%); this may explain the level of missing data pertaining to the ‘highest level of educational attainment’ variable. However, missing data may also be attributable to the WHO data collection ‘Individual Questionnaire’ tool, which did not include a category for those that had completed primary school but who had not completed secondary school. It has been reported that, in several countries, urban dwellers were more likely to refuse to participate in SAGE , which may present a bias toward rural-based participants; however, the high proportion of rural residents may conversely be considered a key strength of the SAGE dataset as non-metropolitan groups are commonly under-represented in population-based surveys. We acknowledge that the six countries differ substantially in terms of culture, society, and healthcare system, and thus our pooled estimates should be considered in this light. Finally, the response rates were relatively low for Mexico (53%), due to a short time-frame for data collection, although response rates for all other countries in SAGE Wave 1 were 75% or greater, with the exception of India at 68% .
In conclusion, we have identified a high prevalence of arthritis in LMICs. For people living in LMIC, functional ability and mobility is imperative to survival, and our findings therefore have implications for prioritising healthcare resources toward arthritis prevention and treatment in relatively resource-poor countries. It is plausible that, especially for residents of LMICs, the high prevalence of arthritis may limit their ability to financially and/or materially support themselves. Similarly, poverty and lower educational attainment may predispose populations to manual labour, and subsequent predisposition to diseases such as osteoarthritis. Future work will focus on occupational types and occupational activities as risk factors for arthritis and related symptomatology. Our current findings have implications for national efforts to achieve universal health coverage and to prioritise healthcare resources toward preventing and/or treating arthritis.
Global burden of disease study
Lower and middle income countries
Models of care
Study on global AGEing and adult health
World Health Organization
Years lived with disability
Briggs AM, Cross MJ, Hoy DG, et al. Musculoskeletal health conditions represent a global threat to healthy aging: a report for the 2015 World Health Organization world report on Ageing and health. Gerontologist. 2016;56(S2):S234–55.
Global Burden of Disease Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800.
Hoy D, Geere JA, Davatchi F, et al. A time for action: opportunities for preventing the growing burden and disability from musucloskeletal conditions in low- and middle-income countries. Best Pract Res Clin Rheumatol. 2014;28(3):377–93.
Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the global burden of disease study. Lancet. 2012;380:2163–96.
Woolf AD, Brooks P, Akesson K, et al. Prevention of musculoskeletal conditions in the developing world. Best Pract Res Clin Rheumatol. 2008;22(4):759–72.
Rudan I, Sidhu S, Papana A, et al. Prevalence of rheumatoid arthritis in low- and middle-income countries: a systematic review and analysis. J Glob Health. 2015;5(1):010409.
Adebayo EF, Uthman OA, Wiysonge CS, et al. A systematic review of factors that affect uptake of community-based health insurance in low-income and middle-income countries. BMC Health Serv Res. 2015;15:543.
Lenssinck M-LB, Burdorf A, Boonen A, et al. Consequences of inflammatory arthritis for workplace productivity loss and sick leave: a systematic review. Ann Rheum Dis. 2013;72:493–505.
Agoliotis M, Fransen M, Bridgett L, et al. Risk factors associated with reduced work productivity among people with chronic knee pain. Osteoarthr Cart. 2013;21(9):1160–9.
United Nations. Prevention and control of non-communicable diseases: report of the secretary-general. New York, United Nations: United Nations; 2011.
Sokka T, Kautiainen H, Pincus R, et al. Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann Rheum Dis. 2009;68:1666–72.
Jonsson B, Kobelt G, Smolen J. The burden of rheumatoid arthritis and access to treatment: uptake of new therapies. Eur J Health Econ. 2008;(Suppl 2):S61–86.
Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81:646–56.
Pabinger C, Geissler A. Utilization rates of hip arthroplasty in OECD countries. Osteoarthr Cart. 2014;22(6):734–41.
Sokka T, Kautiainen H, Pincus R, et al. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. Arthrit Res Ther. 2010;12:R42.
Storheim K, Zwart J-A. Musculoskeletal disorders and the global burden of disease study. Ann Rheum Dis. 2014;73:949–50.
Chopra A, Abdel-Nasser A. Epidemiology of rheumatoid musculoskeletal disorders in the developing world. Best Pract Res Clin Rheumatol. 2008;22:583–604.
Hosseinpoor AR, Bergen N, Mendis S, et al. Socioeconomic inequality in the prevalence of noncommunicable diseases in low- and middle-income countries: results from the world health survey. BMC Public Health. 2012;12:474.
Kumar B. Global health inequities in rheumatology. Rheumatol. 2016; Online First March 24.
Arokiasamy P, Uttamacharya, Kowal P, et al. Chronic noncommunicable diseases in 6 low- and middle-income countries: findings from wave 1 of the World Health Organization's study on global Ageing and adult health (SAGE). Am J Epidemiol. 2017; 185(6):414-428.
Bloom DE, Chatterji S, Kowal P, et al. Macroeconomic implications of population ageing and selected policy responses. Lancet. 2015;385(9968):649–57.
Chatterji S. World Health Organization's (WHO) study global AGEing and adult health (SAGE). BMC Proc. 2013;7(Suppl 4):S1.
Kowal P, Chatterji S, Naidoo N, et al. Data resource profile: the World Health Organization study on global AGEing and adult health (SAGE). Int J Epidemiol. 2012;41(6):1639–49.
UNESCO. International Standard Classification of Education: ISCED. 1997:2006.
Esteve J, Benhamou E, Raymond L. Statistical methods in cancer research. Volume IV. Descriptive epidemiology. IARC Sci Publ. 1994;128:1–302.
Ahmad OB, Boschi-Pinto C, Lopez AD, et al. Age standardization of rates: a new WHO standard. Geneva, Switzerland: WHO; 2001.
Cross M, Smith E, Hoy D, et al. The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014; Online First(Feb 18).
Ackerman IN, Bucknill A, Page RS, et al. The substantial personal burden experienced by younger people with hip or knee osteoarthritis. Osteoarthr Cart. 2015;23(8):1276–84.
Ackerman I, Kemp JL, Crossley KM, et al. Hip and knee osteoarthritis affects younger people too. J Orthop Sports Phys Ther. 2017;47(2):67–79.
Basu S, King AC. Disability and chronic disease among older adults in India: detecting vulnerable populations through the WHO SAGE study. Amer J Epidemiol. 2013;178(11):1620–8.
Wu F, Guo Y, Kowal P, et al. Prevalence of major chronic conditions among older Chinese adults: the study on global AGEing and adult health (SAGE) wave 1. PLoS One. 2013;8(9):e74176.
Brennan SL, Turrell G. Neighborhood disadvantage, individual-level socioeconomic position, and self-reported chronic arthritis: a cross-sectional multilevel study. Arthrit Care Res. 2012;64(5):721–8.
Hannan MT, Anderson JJ, Pincus T, et al. Educational attainment and osteoarthritis: differential associations with radiographic changes and symptom reporting. J Clin Epidemiol. 1992;45(2):139–47.
Bengtsson C, Nordmark B, Klareskog L, et al. Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis. 2005;64:1588–94.
Kirkhorn S, Greenlee RT, Reeser JC. The epidemiology of agriculture-related osteoarthritis and its impact on occupational disability. Wisconsin Med J. 2003;102(7):38–44.
Andersen S, Caspar-Thygesen L, Davidsen M, et al. Cumulative years in occupation and the risk of hip or knee osteoarthritis in men and women: a register-based follow-up study. Occup Environ Med. 2012;69:325–30.
Bond M. Pain education issues in developing countries and responses to them by the International Association for the Study of Pain. Pain Res Manage. 2011;16(6):404–6.
Gureje O, Von Korff M, Simon GE, et al. Persistent pain and well-being: a World Health Organization study in primary care. JAMA. 1998;280:147–51.
WHO. Health and human rights. Geneva, Switzerland: WHo; 2015.
Lim KK, Chan M, Navarra S, et al. Development and implementation of models of care for musculoskeletal conditions in middle-income and low-income Asian countries. Best Pract Res Clin Rheumatol. 2016;30:398–419.
Putrik P, Ramiro S, Keszei AP, et al. Lower education and living in countries with lower wealth are associated with higher disease activity in rheumatoid arthritis: results from the multinational COMORA study. Ann Rheum Dis. 2016; 75(3):540–46.
Mody GM, Cardiel MH. Challenges in the management of rheumatoid arthritis in developing countries. Best Pract Res Clin Rheumatol. 2008;22(4):621–41.
Xu K, Evans DB, Kawabata K, et al. Household catastrophic health expenditure: a multicountry analysis. Lancet. 2003;362:111–7.
Hsiao WC. Experience of community health financing in the Asian Region. In: Preker AS, Currin G, editors. Health financing for poor people: resource mobilization and risk sharing. Washington: World Bank; 2004. p. 119.
WHO. World Report on Disability 2011; Technical Appendix D, Global Burden of Disease Methodology. Geneva: World Health Organization; 2011.
Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Arthrit Rheum. 2008;58(1):15–25.
Sacks JJ, Harrold LR, Hemick CG, et al. Validation of a surveillance case definition for arthritis. J Rheumatol. 2005;32:340–7.
We thank the participants in each country for their contribution to the SAGE, and acknowledge the contributions and expertise of the country-specific investigators and their respective survey teams.
SLB-O is supported by a Career Development Fellowship from the National Health and Medical Research Council (NHMRC) of Australia (1107510). SAGE is supported by WHO and the Division of Behavioral and Social Research (BSR) at the US National Institute on Aging (NIA) through Interagency Agreements (OGHA 04034785; YA1323–08-CN-0020; Y1-AG-1005-01) with WHO and a Research Project Grant R01AG034479. In addition, the governments of China and South Africa provided financial or other support for Wave 1 of their national studies. USAID provided additional funds in support of SAGE India to increase the sample of women aged 15–49 years as a nested study examining health in younger women. All collaborating institutions provided substantial resources to conduct the studies.
Availability of data and materials
The datasets used and analysed during the current study are available from Professor Nirmala Naidoo (World Health Organization) on reasonable request. Permission was granted to access and analyse the data in SAGE Wave 1.
Data collection and harmonization between countries: NN, PK, MM. Conceived and designed the project: SLB-O, SC, MTL, SJB, PK, NN, INA, RSP, SMH, JAP, MM. Analyzed the data: MM, SC, SJB. Interpreted the results: SLB-O, SC, MTL, SJB, PK, NN, INA, RSP, SMH, JAP, MM. Wrote, edited, and approved the final version of this manuscript: SLB-O, SC, MTL, SJB, PK, NN, INA, RSP, SMH, JAP, MM.
None of the authors have any relevant conflicts of interest related to the work under consideration for publication. SLB-O has received speaker fees from Amgen. RSP has received institutional support from De Puy-Synthesis for educational/training purposes.
Consent for publication
Ethics approval and consent to participate
This research was performed in accordance with the Declaration of Helsinki. The WHO and the respective implementing agency in each country provided ethics approvals. Written, informed consent was obtained from all participants.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.